0000898432-20-000871.txt : 20201209 0000898432-20-000871.hdr.sgml : 20201209 20201209215952 ACCESSION NUMBER: 0000898432-20-000871 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201207 FILED AS OF DATE: 20201209 DATE AS OF CHANGE: 20201209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scott Christopher K. CENTRAL INDEX KEY: 0001613803 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36534 FILM NUMBER: 201379312 MAIL ADDRESS: STREET 1: C/O IRADIMED CORPORATION STREET 2: 1025 WILLA SPRINGS DR. CITY: WINTER SPRINGS STATE: FL ZIP: 32708 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IRADIMED CORP CENTRAL INDEX KEY: 0001325618 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 731408526 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1025 WILLA SPRINGS DR. CITY: WINTER SPRINGS STATE: FL ZIP: 32708 BUSINESS PHONE: 4076778022 MAIL ADDRESS: STREET 1: 1025 WILLA SPRINGS DR. CITY: WINTER SPRINGS STATE: FL ZIP: 32708 4 1 form4.xml X0306 4 2020-12-07 0001325618 IRADIMED CORP IRMD 0001613803 Scott Christopher K. C/O IRADIMED CORPORATION 1025 WILLA SPRINGS DR. WINTER SPRINGS FL 32708 true CFO & Secretary Common Stock 2020-12-07 4 M 0 1575 A 24840 D Common Stock 2019-12-07 4 F 0 384 24.54 D 24456 D Common Stock 2020-12-07 4 M 0 2731 A 27187 D Common Stock 2019-12-07 4 F 0 665 24.54 D 26522 D Restricted Stock Units 2020-12-07 4 A 0 5094 0 A Common Stock 5094 5094 D Performance-Based Restricted Stock Units 2020-12-07 4 A 0 5093 0 A Common Stock 5093 5093 D Restricted Stock Units 2020-12-07 4 M 0 1575 0 D Common Stock 1575 3150 D Restricted Stock Units 2020-12-07 4 M 0 2731 0 D Common Stock 2731 8195 D Restricted stock units convert into common stock on a one-for-one basis. Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in full on the third anniversary of the grant date, December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. The reporting person received performance-based restricted stock units ("PRSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. Vesting of these PRSUs depends on the reporting person's achievement of a specified relative ranking of total stockholder return over a three-year period from December 8, 2020 through December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of PRSUs that have vested. On December 7, 2018, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. On December 7, 2019, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. /s/ Christopher K. Scott 2020-12-09